poisar

Stock

RxSight, Inc. RXST

$6.60+3.53%

Overview

RXST market data

Price History

RXST price chart · 1M
O
6.32
H
6.68
L
6.31
C
6.60
Vol
33,694.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$6.32
Previous Close
$6.38
Day High
$6.68
Day Low
$6.31
52 Week High
$7.49
52 Week Low
$4.52
7 Day Return
+8.37%
30 Day Return
+8.91%
90 Day Return
+24.06%
1 Year Return
-3.44%
Daily Notional Volume
$222.4K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.95
Diluted earnings per share over the trailing twelve months.
Beta
1.10
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-36.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$4.48 – $13.22
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $291.6M · P/B 1.55 · P/S 2.29.

Company News

10 captured
Stifel Maintains Hold on RxSight, Lowers Price Target to $7Benzinga · Aug 10, 2026, 12:31 PM
UBS Maintains Neutral on RxSight, Raises Price Target to $6.3Benzinga · Aug 6, 2026, 7:39 PM
RxSight Q2 Adj. EPS $(0.11) Beats $(0.33) Estimate, Sales $33.741M Beat $32.547M EstimateBenzinga · Aug 5, 2026, 8:08 PM
8-K filing — RxSight, Inc. (RXST)SEC EDGAR · Jul 15, 2026, 8:23 PM
RxSight Appoints Aziz Mottiwala President, CEO, Effective July 20, Succeeding Ron KurtzBenzinga · Jul 15, 2026, 8:16 PM
B of A Securities Maintains Underperform on RxSight, Lowers Price Target to $6.5Benzinga · Jul 7, 2026, 5:25 PM
Stock Market Today: Dow Jones Futures Gain, S&P 500, Nasdaq 100 Slips As SpaceX Debuts On The Exchange—Rivian, Micron In Focus (UPDATED)Benzinga · Jul 7, 2026, 12:40 PM
RxSight Sees Q2 Sales $32.000M-$34.000M vs $32.077M EstBenzinga · Jul 6, 2026, 8:55 PM
RxSight Raises FY2026 Sales Guidance from $120.000M-$135.000M to $140.000M-$160.000M vs $129.250M EstBenzinga · Jul 6, 2026, 8:55 PM
RxSight Sees Q2 Revenue Of $32M-$34M; Sees FY2026 Revenue Of $140M-$160MBenzinga · Jul 6, 2026, 8:20 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock